Backing BIO, Genomics Firms Urge Bush to Bolster Patent Office Resources | GenomeWeb

WASHINGTON, Jan 22 - Genomics firms are backing a recent plea by the biotech industry urging the Bush Administration to address ongoing patent and research priorities in the coming legislative year.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.